NCT02314689View on ClinicalTrials.gov

A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Sickle Cell Disease
Interventions
DRUG

Intravenous (IV) citrulline

Trial Locations (1)

39216

University of Mississippi Medical Center, Jackson

All Listed Sponsors
lead

Suvankar Majumdar

OTHER

NCT02314689 - A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease | Biotech Hunter | Biotech Hunter